Avalo Therapeutics (AVTX) Inventory (2017 - 2023)

Avalo Therapeutics (AVTX) has 7 years of Inventory data on file, last reported at $18000.0 in Q2 2023.

• Quarterly Inventory fell 21.74% year-over-year to $18000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $18000.0 (down 21.74% YoY) and the FY2022 annual result came in at $20000.0, down 47.37% from the prior year.
• Inventory retreated to $18000.0 in Q2 2023, from $19000.0 in the prior quarter.
• In the past five years, Inventory ranged from a high of $1.0 million in Q1 2019 to a low of $3000.0 in Q4 2020.
• A 5-year average of $107007.2 and a median of $20000.0 in 2021 frame the typical range for Inventory.
• Annual changes were most pronounced in 2020 — Inventory slumped 98.45% — and 2021, when it jumped 1166.67%.
• Tracing AVTX's Inventory over 5 years: stood at $21334.0 in 2019, then plunged by 85.94% to $3000.0 in 2020, then jumped by 1166.67% to $38000.0 in 2021, then slumped by 47.37% to $20000.0 in 2022, then declined by 10.0% to $18000.0 in 2023.
• The last three Inventory figures came in at $18000.0 (Q2 2023), $19000.0 (Q1 2023), and $20000.0 (Q4 2022), per Business Quant data.